Circulating tumor DNA (ctDNA) heterogeneity as first- and third-line treatment in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab

被引：0
|
作者：
Parseghian, Christine Megerdichian
Beutner, Karl
Boedigheimer, Michael
Ruff, Paul
Price, Timothy Jay
Kim, Tae Won
Fakih, Marwan
Ang, Agnes
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Newbury Pk, CA USA
[4] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[5] Queen Elizabeth Hosp, Adelaide, SA, Australia
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[7] City Hope Comprehens Canc Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
238
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC).
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    Ohta, Takashi
    Denda, Tadamichi
    Satoh, Taroh
    Yamazaki, Kentaro
    Sunakawa, Yu
    Kato, Takeshi
    Goto, Masahiro
    Yuki, Satoshi
    Nishina, Tomohiro
    Oki, Eiji
    Shinozaki, Eiji
    Matsuhashi, Nobuhisa
    Hata, Masayuki
    Yoshino, Takayuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Circulating tumor (ct) DNA captures intrapatient heterogeneity in metastatic colorectal (mCRC) patients (pts) progressing to FOLFIRI plus panitumumab
    Vidal, J.
    Vieitez, J. M.
    Paez, D.
    Santos, C.
    Falco, E.
    Lopez Lopez, C.
    Valladares-Ayerbes, M.
    Robles, L.
    Garcia-Alfonso, P.
    Duran Ogaya, G.
    Azuara, D.
    Dalmeses, A.
    Bellosillo Paricio, B.
    Capella, G.
    Salazar, R.
    Aranda Aguilar, E.
    Montagut, C.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy
    Ghidini, M.
    Hahne, J. C.
    Senti, C.
    Tomasello, G.
    Ratti, M.
    Heide, T.
    Garrone, O.
    Cortellini, A.
    Passalacqua, R.
    Valeri, N.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [4] Predictors for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Loree, Jonathan M.
    Davis, Jennifer S.
    Lam, Michael
    Morris, Van Karlyle
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Kee, Bryan K.
    Fogelman, David R.
    Sanchez, Eduardo Vilar
    Shureiqi, Imad
    Eng, Cathy
    Manuel, Shanequa
    Crosby, Shadarra
    Wolff, Robert A.
    Lanman, Richard B.
    Talasaz, AmirAli
    Janku, Filip
    Kopetz, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy.
    Ghidini, Michele
    Hahne, Jens Claus
    Senti, Chiara
    Tomasello, Gianluca
    Ratti, Margherita
    Heide, Timon
    Garrone, Ornella
    Cortellini, Alessio
    Passalacqua, Rodolfo
    Valeri, Nicola
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 175 - 175
  • [6] Clinical utility of upfront circulating tumor DNA (ctDNA) genotyping to guide first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC): A GOZILA substudy.
    Aoki, Yu
    Nakamura, Yoshiaki
    Komatsu, Yoshito
    Taniguchi, Hiroya
    Sunakawa, Yu
    Shiozawa, Manabu
    Kitagawa, Chiyoe
    Ohta, Takashi
    Matsuhashi, Nobuhisa
    Yamazaki, Kentaro
    Boku, Shogen
    Takahashi, Naoki
    Esaki, Taito
    Kawakami, Hisato
    Kagawa, Yoshinori
    Nishina, Tomohiro
    Yamaguchi, Kensei
    Bando, Hideaki
    Yoshino, Takayuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 157 - 157
  • [7] Prediction model for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Parikh, Aparna Raj
    Van Seventer, Emily E.
    Jia, Jingquan
    Loree, Jonathan M.
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Overman, Michael J.
    Raymond, Victoria M.
    Lanman, Richard B.
    Talasaz, AmirAli
    Strickler, John H.
    Corcoran, Ryan Bruce
    Kopetz, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
  • [9] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Antoniotti, C.
    Loupakis, F.
    Schirripa, M.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    D'Aurizio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Dell'Aquila, E.
    Pellegrini, M.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 37 - 38
  • [10] Irinotecan combined with Panitumumab or cetuximab as third-line treatment for metastatic colorectal cancer.
    Braghiroli, Maria Ignez
    Batistuzzo Vicentini, Maria Fernanda
    da Fonseca, Leonardo Gomes
    Souza, Karla Teixeira
    Bonadio, Renata Colombo
    Melro Braghiroli, Oddone Freitas
    Machado Mathias, Maria Cecilia
    Talans, Aley
    Zambrano Mendoza, Maria Elizabeth
    Martins, Juliana Goes
    Sabagga, Jorge
    Motta Venchiarutti Moniz, Camila Venchiarutti
    Hoff, Paulo Marcelo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15551 - E15551
12345